SCHEMBL25461900

SCHEMBL25461900

c1ccc2c(-c3cc4sc5ccncc5c4cn3)nccc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.36
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
GPR55 Q9Y2T6 1/20 0.36
HTT P42858 2/20 0.36
TNF P01375 1/20 0.36
POLB P06746 1/20 0.36
RAD52 P43351 1/20 0.36
MAPT P10636 3/20 0.36
KMT2A Q03164 2/20 0.36
GLA P06280 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HTR2C P28335 1/20 0.35
MAPK10 P53779 1/20 0.35
NPY5R Q15761 1/20 0.34
CYP2A6 P11509 1/20 0.34
F12 P00748 1/20 0.34
PLAU P00749 1/20 0.34
NCF1 P14598 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25462010 0.92 GPR3 (0.37) KDM4ENPC1RAB9AL3MBTL1HTT
SCHEMBL25461854 0.91 KDM4E (0.35) KDM4ENPC1RAB9AL3MBTL1GPR55
SCHEMBL25461845 0.91 KDM4E (0.36) KDM4ENPC1RAB9AL3MBTL1GPR55
SCHEMBL25461707 0.91 GPR3 (0.40) KDM4ENPC1RAB9AL3MBTL1GPR55
SCHEMBL25462008 0.88 MAPT (0.38) KDM4ENPC1RAB9AL3MBTL1HTT
SCHEMBL25462146 0.84 CYP2A6 (0.35) KDM4ENPC1RAB9AL3MBTL1GPR55
SCHEMBL25461777 0.82 HTR2C (0.37) KDM4ENPC1RAB9AL3MBTL1GPR55
SCHEMBL25462007 0.82 GABRA1 (0.38) KDM4ENPC1RAB9AL3MBTL1HTT
SCHEMBL25461885 0.81 NPC1 (0.40) KDM4ENPC1RAB9AHTTTNF
SCHEMBL25461880 0.81 HTR2C (0.37) KDM4ENPC1RAB9AL3MBTL1GPR55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE OCIAD1, OCIAD2, EHD1 KDM4E 2555/4885NPC1 1557/4885RAB9A 756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.